F Witz
Overview
Explore the profile of F Witz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
310
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Allogeneic Bone Marrow Transplantation in Chronic Lymphocytic Leukemia: 17 Cases. Report of the EBMT
Michallet M, Corront B, Molina L, Gratwohl A, Milpied N, Dauriac C, et al.
Leuk Lymphoma
. 2016 Jul;
5 Suppl 1:127-31.
PMID: 27463494
Allogeneic bone marrow transplantation (BMT) was performed in 17 patients with chronic lymphocytic leukemia (CLL): 15 resistant and 2 untreated forms; 12 males and 5 females with a mean age...
2.
Park S, Chapuis N, Saint Marcoux F, Recher C, Prebet T, Chevallier P, et al.
Leukemia
. 2013 Jan;
27(7):1479-86.
PMID: 23321953
The mTORC1 signaling pathway is constitutively activated in almost all acute myelogenous leukemia (AML) patients. We conducted a phase Ib trial combining RAD001 (everolimus), an allosteric inhibitor of mTORC1, and...
3.
Bay J, Cabrespine A, Faucher C, Tabrizi R, Bordigoni P, Berceanu A, et al.
Biol Blood Marrow Transplant
. 2011 Jul;
18(2):250-6.
PMID: 21745455
The purpose of this paper is to describe the outcome of patients who underwent double allogeneic hematopoietic stem cell transplantation (AHSCT) with reduced-intensity conditioning regimens (RIC). Forty-five patients who received...
4.
Lacombe F, Arnoulet C, Maynadie M, Lippert E, Luquet I, Pigneux A, et al.
Leukemia
. 2008 Nov;
23(2):350-7.
PMID: 18987664
An early appreciation of treatment efficacy could be very useful in acute myeloblastic leukemia (AML), and a prognostic value has been suggested for the morphological assessment of decrease in blasts...
5.
Bardet V, Costa L, Elie C, Malinge S, Demur C, Tamburini J, et al.
Leukemia
. 2006 Jun;
20(9):1644-6.
PMID: 16791266
No abstract available.
6.
Dhedin N, Dombret H, Thomas X, Lheritier V, Boiron J, Rigal-Huguet F, et al.
Leukemia
. 2005 Dec;
20(2):336-44.
PMID: 16357838
To evaluate the results of autologous stem cell transplantation (ASCT) in a large population of adults with acute lymphoblastic leukemia (ALL) in first complete remission (CR), we performed an individual...
7.
Witz F, Harousseau J, Guilhot F, Cahn J, Witz B, Loos C, et al.
Ann Hematol
. 2004 May;
83 Suppl 1:S55-7.
PMID: 15124672
No abstract available.
8.
Depil S, Deconinck E, Milpied N, Sutton L, Witz F, Jouet J, et al.
Bone Marrow Transplant
. 2004 Jan;
33(5):531-4.
PMID: 14716345
Donor lymphocyte infusion has become established as a salvage therapy for patients with hematological disorders relapsing after allogeneic bone marrow transplantation (BMT). The role of donor lymphocyte infusion for patients...
9.
Dimicoli S, Feugier P, Delaby P, Cannard L, Bland V, Witz F, et al.
Presse Med
. 2002 Aug;
31(22):1024-6.
PMID: 12148256
Introduction: Granulocyte sarcoma (GS), also known as chloroma, is a localized malignant tumor composed of myeloid cells, the diagnosis of which is difficult. The pancreatic location and recurrence, aside from...
10.
Pigneux A, Tanguy M, Michallet M, Jouet J, Kuentz M, Vernant J, et al.
Br J Haematol
. 2002 Feb;
116(1):193-201.
PMID: 11841417
The timing of transplantation in chronic myeloid leukaemia is still debated and previous treatment with interferon (IFN) alpha has been reported to be deleterious. We have analysed the outcome of...